Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome

ClinicalTrials.gov ID: NCT00002127

Public ClinicalTrials.gov record NCT00002127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00002127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene Corporation
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • Thalidomide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Marin County Specialty Clinic Greenbrae California 94904
AIDS Community Research Consortium Redwood City California 940631633
UCSD Med Ctr - Owen Clinic San Diego California 921038681
San Francisco Gen Hosp San Francisco California 94110
Kaiser Permanente Med Ctr San Francisco California 94115
Gottlieb Med Group Sherman Oaks California 91403
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037
Community Research Initiative of South Florida Coral Gables Florida 33146
Kansas City AIDS Research Consortium Kansas City Missouri 64111
Saint Michael's Med Ctr Newark New Jersey 07102
Rockefeller Univ New York New York 10021
Thomas Jefferson Med College Philadelphia Pennsylvania 19107
Advanced Research Management Seattle Washington 981225314

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →